OBL Pharm

89, Krasnobogatyrskaya street,
Moscow, 107076
Russia,
+7 (495) 646 28 68
www.obolensk.ru

OBL Pharm, a major Russian generic drug manufacturer that was established in 1994. The company is specializing in heart & blood as well as digestive system diseases and is currently producing over 100 types of drugs. Production facilities are located in the Moscow region (Obolensk) and its business strategy is focused on commercial sales channel and branded products.

OBL Pharm was acquired by UFG Private Equity on September 01, 2013.

Join Mergr to view all 341 acquisitions of healthcare services companies in 2013, including 58 acquisitions by private equity firms, and 283 by strategics.

Out of 60 sectors in the Mergr database, healthcare services ranked 4 in number of deals in 2013. The largest healthcare services acquisition in 2013 was Elan - which was acquired by Perrigo Company for $8.6B.

Join Mergr to view this profile - and discover more healthcare services acquisitions of companies like OBL Pharm.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 112K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.